While mutations in tumor suppressor genes allow for uncontrolled cell proliferation and cell cycle progression, the driver mutation present in many urothelial carcinomas is mutation or gene fusion of the fibroblast growth factor receptor 3 (FGFR3) [58]. The gene discussed is FGFR3; the disease is urothelial carcinoma.